Zobrazeno 1 - 10
of 579
pro vyhledávání: '"Benigno M"'
Publikováno v:
Boletín Médico del Hospital Infantil de México, Vol 80, Iss 5 (2023)
Background: Urinary tract infection (UTI) is infants’ most common serious bacterial infection. This study aimed to investigate the reliability of urianalysis (UA) to predict UTI, to specify the colony forming units (CFU)/ml threshold for diagnosis,
Externí odkaz:
https://doaj.org/article/b4032f8b28fa491782295d2a9384c88b
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 13, Pp 593-602 (2021)
Anita H Sung,1 Stephan Martin,2 Bryant Phan,1 Michael Benigno,1 Jennifer Stephens,2 Richard Chambers,1 Jalal A Aram1 1Pfizer Inc, New York, NY, USA; 2OPEN Health, Bethesda, MD, USACorrespondence: Anita H SungPfizer, 235 E 42nd St, New York, NY, 10017
Externí odkaz:
https://doaj.org/article/71b1072e3ec64f73af50431c1cddc073
Autor:
Benigno M, Anastassopoulos KP, Mostaghimi A, Udall M, Daniel SR, Cappelleri JC, Chander P, Wahl PM, Lapthorn J, Kauffman L, Chen L, Peeva E
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology, Vol Volume 13, Pp 259-266 (2020)
Michael Benigno,1 Kathryn P Anastassopoulos,2 Arash Mostaghimi,3 Margarita Udall,1 Shoshana R Daniel,1 Joseph C Cappelleri,4 Pratibha Chander,1 Peter M Wahl,2 Jennifer Lapthorn,2 Laura Kauffman,2 Linda Chen,1 Elena Peeva5 1Pfizer Inc, New York, NY 10
Externí odkaz:
https://doaj.org/article/1e1cc3a3770d423f87d5416dbe54c933
Autor:
Hammond J; Pfizer, Collegeville, PA, USA., Benigno M; Pfizer Biopharmaceutical Group, Pfizer Inc., 66 Hudson Blvd East, New York, NY, 10001, USA., Bleibdrey N; Pfizer Biopharmaceutical Group, Pfizer Inc., 66 Hudson Blvd East, New York, NY, 10001, USA., Ansari W; Pfizer Biopharmaceutical Group, Pfizer Inc., 66 Hudson Blvd East, New York, NY, 10001, USA. wajeeha.ansari@pfizer.com., Nguyen JL; Pfizer Biopharmaceutical Group, Pfizer Inc., 66 Hudson Blvd East, New York, NY, 10001, USA.
Publikováno v:
Drugs - real world outcomes [Drugs Real World Outcomes] 2024 Jun; Vol. 11 (2), pp. 273-283. Date of Electronic Publication: 2024 Apr 02.
Autor:
Kitsios GD; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA kitsiosg@upmc.edu.; Center for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Blacka S; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Jacobs JJ; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Mirza T; Internal Medicine Residency Program, UPMC in Central Pa, Harrisburg, Pennsylvania, USA., Naqvi A; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Gentry H; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Murray C; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Wang X; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Golubykh K; Internal Medicine Residency Program, UPMC in Central Pa, Harrisburg, Pennsylvania, USA., Qurashi H; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Dodia A; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Risbano M; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Benigno M; Pfizer Inc, New York, New York, USA., Emir B; Pfizer Inc, New York, New York, USA., Weinstein E; Pfizer Inc, New York, New York, USA., Bramson C; Pfizer Inc, New York, New York, USA., Jiang L; Pfizer Inc, New York, New York, USA., Dai F; Pfizer Inc, New York, New York, USA., Szigethy E; Department of Psychiatry and Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Mellors JW; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Methe B; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Center for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Sciurba FC; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Emphysema Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Nouraie SM; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Morris A; Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Center for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Publikováno v:
BMJ open [BMJ Open] 2024 Mar 14; Vol. 14 (3), pp. e077869. Date of Electronic Publication: 2024 Mar 14.
Autor:
Scott A; Global Real World Evidence, Pfizer Inc, 235 East 42nd Street, New York, NY, 10017, USA. Amie.scott@pfizer.com., Ansari W; Global HEOR, Pfizer Inc, New York, NY, USA., Chambers R; Global Product Development Statistics, Pfizer Inc, New York, NY, USA., Reimbaeva M; Global Biometrics and Data Management, Pfizer Inc, Groton, CT, USA., Mikolajczyk T; Quanticate, Warsaw, Poland., Benigno M; Global Real World Evidence, Pfizer Inc, 235 East 42nd Street, New York, NY, 10017, USA., Draica F; Medical Affairs, Pfizer Inc, New York, NY, USA., Atkinson J; Medical Affairs, Pfizer Ltd, Tadworth, Surrey, UK.
Publikováno v:
BMC medicine [BMC Med] 2024 Feb 02; Vol. 22 (1), pp. 47. Date of Electronic Publication: 2024 Feb 02.
Autor:
Scott A; Global Real World Evidence, Pfizer Inc, New York, NY, USA. Amie.scott@pfizer.com., Ansari W; Global HEOR, Pfizer Inc, New York, NY, USA., Khan F; Vaccines Medical Development & Scientific Clinical Affairs, Pfizer Inc, New York, NY, USA., Chambers R; Global Product Development Statistics, Pfizer Inc, New York, NY, USA., Benigno M; Global Real World Evidence, Pfizer Inc, New York, NY, USA., Di Fusco M; Global HEOR, Pfizer Inc, New York, NY, USA., McGrath L; Global Real World Evidence, Pfizer Inc, New York, NY, USA., Malhotra D; Global Real World Evidence, Pfizer Inc, New York, NY, USA., Draica F; Medical Affairs, Pfizer Inc, New York, NY, USA., Nguyen J; Vaccines Medical Development & Scientific Clinical Affairs, Pfizer Inc, New York, NY, USA., Atkinson J; Medical Affairs, Pfizer Ltd, Tadworth, Surrey, UK., Atwell JE; Vaccines Medical Development & Scientific Clinical Affairs, Pfizer Inc, New York, NY, USA.
Publikováno v:
BMC medicine [BMC Med] 2024 Feb 01; Vol. 22 (1), pp. 46. Date of Electronic Publication: 2024 Feb 01.
Publikováno v:
Boletín Médico del Hospital Infantil de México; sep/oct2023, Vol. 80 Issue 5, p288-295, 8p
Autor:
Gerhart J; Pfizer Inc, Global Product Development, 500 Arcola Road, Collegeville, Pennsylvania, 19426, USA. jacqueline.gerhart@pfizer.com., Draica F; Pfizer Inc, US Medical Affairs, Hospital, New York, New York, USA., Benigno M; Pfizer Inc, Real World Evidence, New York, New York, USA., Atkinson J; Pfizer Ltd, Medical Affairs, Tadworth, UK., Reimbaeva M; Pfizer Inc, Global Biometrics and Data Management, Groton, Connecticut, USA., Francis D; Pfizer Inc, US Medical Affairs, Hospital, New York, New York, USA., Baillon-Plot N; Pfizer Inc, Global Medical Affairs, Paris, France., Sidhu GS; Pfizer Inc, US Medical Affairs, Hospital, Los Angeles, California, USA., Damle BD; Pfizer Inc, Global Product Development, New York, New York, USA.
Publikováno v:
The AAPS journal [AAPS J] 2023 Jul 20; Vol. 25 (5), pp. 73. Date of Electronic Publication: 2023 Jul 20.
Autor:
Gianna M. Garda, Benigno M. Garda
Publikováno v:
Geologia USP. Série Científica, Vol 1, Pp 17-44 (2001)
Ao longo do litoral norte do Estado de São Paulo, diques alcalinos e de composições variando desde básicas a intermediáriasocorrem paralelamente aos lineamentos de direção geral NE-SW do Complexo Costeiro precambriano. As composições alcalin
Externí odkaz:
https://doaj.org/article/014586cb668c4a9bb5a98783db1cb978